Building partnerships to target sickle cell anemia in Africa
A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial
The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma
Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5′-nucleotidase
Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis
World Health Organization-defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations—The Danish experience
Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34+ hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma
Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors
The Canadian “National Program for hemophilia mutation testing” database: A ten-year review
Hyperimmune globulins and same-day thrombotic adverse events as recorded in a large healthcare database during 2008–2011
Thrombopoietin levels in patients with disorders of platelet production: Diagnostic potential and utility in predicting response to TPO Receptor agonists
Transferrin-immune complex disease: A potentially overlooked gammopathy mediated by IgM and IgG
Associations between allergies and risk of hematologic malignancies: Results from the VITamins and lifestyle cohort study
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy
Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: Two-year results including pharmacokinetics and concomitant hydroxyurea
Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status
Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management
Diagnosis of pyrimidine 5′-nucleotidase deficiency suspected from a blood film
Blue toes and a new pair of shoes—Challenges in diagnosis and treatment of acute myelogenous leukemia
Intracellular and extracellular immunoglobulin crystals assuming a multitude of geometric shapes in an IgG-λ plasma cell neoplasm
Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia
VARIATION IN THE TREATMENT OF STROKE IN SICKLE CELL DISEASE: A SURVEY OF PROVIDERS : 329
PITFALLS OF USING ADMINISTRATIVE DATA SETS TO DESCRIBE CLINICAL CARE IN SICKLE CELL DISEASE : 306
REDUCING 30 DAY READMISSION RATES IN CHILDREN AND YOUNG ADULTS WITH SICKLE CELL DISEASE : 254
NURSES' ATTITUDES TOWARDS PATIENTS WITH SICKLE CELL DISEASE : 332
EVALUATION OF THE PEDIATRIC PROMIS HEALTH DOMAINS IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE (SCD)-COMPARISON TO PEDS QL SCALE SCORES : 326
EVIDENCE OF ALTERED PAIN PROCESSING IN ADOLESCENTS AND YOUNG ADULTS WITH SICKLE CELL DISEASE : 376
UTILIZATION AND OUTCOME OF BONE MARROW TRANSPLANTATION IN CHILDREN WITH SICKLE CELL DISEASE: A PEDIATRIC HEALTH INFORMATION SYSTEM DATABASE ANALYSIS : 236
EDUCATING PATIENTS AND PHYSICIANS ON HEMATOPOIETIC CELL TRANSPLANTATION AS A VIABLE TREATMENT OPTION FOR SICKLE CELL DISEASE : 257
DECISIONS ABOUT TRANSPLANT IN PEDIATRIC SICKLE CELL DISEASE: ARE FAMILIES AND PROVIDERS ON THE SAME PAGE? : 316
IMPROVED ANEMIA, ORGANOMEGALY AND SUSTAINED FETAL HEMOGLOBIN INDUCTION WITHIN AGING TR2/TR4 OVEREXPRESSING HUMANIZED SICKLE CELL MICE. : 344
EVALUATION OF THE IMPACT OF A WEB-BASED EDUCATIONAL TOOL ON AWARENESS OF NEWBORN SCREENING AND CARRIER TESTING : 244
A NEW PLAY ON AN OLD WAY: SICKLE CELL TRAIT EDUCATION THAT REALLY WORKS : 303
A FOUR YEAR PERSPECTIVE ON THE ISSUES AND CONCERNS OF MANDATORY SICKLE CELL TRAIT TESTING IN COLLEGE ATHLETES : 234
QUALITATIVE STUDY OF THE APPLICABILITY AND FEASIBILITY OF A WEB-BASED PAIN DIARY FOR ADOLESCENTS AND YOUNG ADULTS WITH SICKLE CELL DISEASE : 237
ASSESSING HEALTH MAINTENANCE FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE CHART REVIEW OF PEDIATRIC SICKLE CELL PATIENTS AT UNIVERSITY OF ILLINOIS HOSPITAL : 395
IMPROVING QUALITY OF CARE FOR SICKLE CELL PATIENTS IN THE PEDIATRIC EMERGENCY DEPARTMENT : 427
DEVELOPMENT OF PRIMARY CARE PROVIDER MEDICAL HOMES FOR PATIENTS WITH SICKLE CELL DISEASE : 267
MATERNAL AND PERINATAL OUTCOME IN PREGNANT WOMEN WITH SICKLE CELL DISEASE AND RISK ASSESSMENT OF NEAR MISS OR MATERNAL DEATH: PROSPECTIVE STUDY OF PROJECT ANINHA IN MINAS GERAIS, BRAZIL. : 386
ISCHEMIC STROKE PREVENTION IN SICKLE CELL DISEASE: DATA FROM BELO HORIZONTE BLOOD CENTER, BRAZIL : 388
A SIMPLE, RAPID, LOW-COST DIAGNOSTIC TEST FOR SICKLE CELL DISEASE : 249
EVIDENCE OF ALTERED PAIN PROCESSING IN ADOLESCENTS AND YOUNG ADULTS WITH SICKLE CELL DISEASE : 376
CHOOSING OPIOID MANAGEMENT FOR PAIN AND ANALYZING ACS RATES EQUALLY (COMPARE) : 318
CLINICALLY MEANINGFUL MEASUREMENT OF PAIN IN CHILDREN WITH SICKLE CELL DISEASE : 391
THE DEVELOPMENT AND VALIDATION OF THE CHILDREN'S ACUTE PAIN-FUNCTIONAL ABILITY QUESTIONNAIRE : 434
INDIVIDUALIZED PAIN MANAGEMENT AND USE OF PATIENT CONTROLLED ANALGESIA CAN LEAD TO HIGH QUALITY CARE AND HIGH PATIENT SATISFACTION IN THE PEDIATRIC EMERGENCY DEPARTMENT : 317
MEASURES OF CLINICAL OUTCOMES IN VASO-OCCLUSIVE CRISIS OF SICKLE CELL DISEASE- GRADING THE LITERATURE : 397
PULMONARY FUNCTION TESTING IN INFANTS WITH SICKLE CELL DISEASE : 264
ABNORMAL RENAL TUBULAR HANDLING OF PHOSPHORUS IN SICKLE CELL DISEASE : 321
PREVALENCE OF CYP2D6, CYP2C9 AND CYP2C19 ALLELIC VARIANTS IN A PEDIATRIC SICKLE CELL DISEASE PATIENT COHORT : 368
LONGITUDINAL NATURAL HISTORY STUDY OF TRICUSPID REGURGITANT JET VELOCITY IN UNTREATED CHILDREN WITH SICKLE CELL DISEASE : 402
Red Blood Cell Alloimmunization is Associated with Transfusion for Acute Sickle Cell disease-Related Complications : 246
EVALUATION OF PURIFIED POLOXAMER 188 IN CHILDREN (EPIC) - KEY DESIGN CONSIDERATIONS : 364
UNHEALTHY ALCOHOL USE AMONG PERSONS WITH SICKLE CELL DISEASE: PREVALENCE AND ASSOCIATION WITH CLINICAL OUTCOMES : 328
PERCEIVED STIGMA AND EMERGENCY DEPARTMENT VISITS FOR SICKLE CELL DISEASE PAIN : 266
AN INNOVATIVE APPROACH TO ENHANCING THE TRANSITION TO ADULT CARE IN SICKLE CELL DISEASE : 314
Among Emergency Physicians, Use of the Term Sickler is Associated with Negative Attitudes Towards People with Sickle Cell Disease : 319
PATIENTS WITH SICKLE CELL DISEASE REPORT POORER COMMUNICATION THAN NATIONAL ESTIMATES OF AFRICAN-AMERICANS' EXPERIENCES : 327
POPULATION-BASED SURVEILLANCE FOR SICKLE CELL DISEASE: PAST, PRESENT, FUTURE : 374
IN VITRO HUMAN AND PRECLINICAL ANIMAL STUDIES OF ADENOSINE-BASED THERAPIES IN SICKLE CELL DISEASE : 428
Prasugrel in Children with Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Characteristics from an Open-Label, Adaptive-Design, Dose-Ranging Study : 382
DISEASE-SPECIFIC KNOWLEDGE VS. FUNCTIONAL HEALTH LITERACY AMONG CAREGIVERS OF CHILDREN WITH SICKLE CELL: IS THERE A DIFFERENCE? : 265
EMERGENCY PROVIDER ATTITUDES TOWARDS SICKLE CELL PATIENTS : 308
URINE SCREENING FOR BIOMARKERS OF ACUTE AND CHRONIC KIDNEY INJURY IN CHILDREN AND ADULTS WITH SICKLE CELL ANEMIA WITH AND WITHOUT ALBUMINURIA : 238
HYDROXYUREA DECISION-MAKING DETERMINANTS IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE : 367
DISTANCE LEARNING-TEACHING PROCESS AMONG PRIMARY HEALTH CARE PROFESSIONALS IN THE STATE OF MINAS GERAIS, BRAZIL : 389
PERCEPTIONS OF ADOLESCENTS AND YOUNG ADULTS REGARDING SCHOOL AND ENVIRONMENTAL ISSUES RELATED TO SICKLE CELL DISEASE : 243
Patient Perceptions of Treatment Options for Sickle Cell Disease: Transplant, Hydroxyurea & Gene Therapy : 352
UTILIZATION OF SOCIAL MEDIAS AND ITS IMPACT ON PATIENT AND PROVIDER SICKLE CELL EDUCATION : 426
Primary Care Providers Comfort Levels in Caring for Patients with Sickle Cell Disease : 431
TRAINING PATIENT NAVIGATORS FOR RECRUITING PATIENTS TO SICKLE CELL DISEASE SPECIALTY CARE: THE SHIP HU STUDY : 323
Hemoglobin in Sickle Cell Anemia Is Positively Correlated with 25-hydroxyvitamin D, the Clinical Indicator of Vitamin D Status : 324
ALPHA THALASSEMIA AND TNF-A G308A POLYMORPHISM INFLUENCES THE RISK OF STROKE IN CHILDREN WITH SICKLE CELL ANEMIA : 387
7TESIA BRAIN MRI PILOT/FEASIBILITY STUDY OF COGNITIVE IMPAIRMENT IN ADULT PATIENTS WITH HBSS DISEASE : 230
NOVEL APPROACH TO DESCRIBING PAIN IMPACT ON FUNCTION OF SICKLE CELL YOUTH HOSPITALIZED FOR VASOOCCLUSIVE PAIN : 399
POPULATION-BASED ANALYSIS OF HIGH HOSPITAL UTILIZATION (HHU) AMONG CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE (SCD) : 409
HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SICKLE CELL DISEASE IN AN EIGHT-YEAR-OLD GIRL WITH SIGNIFICANT PSYCHOSOCIAL RISK FACTORS: AN ETHICAL CASE STUDY : 418
PREVALENCE OF THE BETA-S GENE AMONG SCHEDULED CASTES, SCHEDULED TRIBES AND OTHER BACKWARD CLASSES IN CENTRAL INDIA : 233
TRAINING PROVIDERS ON ISSUES OF RACE AND RACISM TO IMPROVE HEALTH CARE EQUITY : 310
VIRTUAL MENTOR PROGRAM FOR YOUNG ADULTS WITH SICKLE CELL DISEASE TRANSITIONING FROM PEDIATRIC TO ADULT CARE : 350
FURTHER EVIDENCE FOR VALIDATION OF THE ADOLESCENT PEDIATRIC PAIN TOOL IN YOUTH WITH SICKLE CELL HOSPITALIZED FOR VASOOCCLUSIVE PAIN : 401
THE PSYCHOSOCIAL FUNCTIONING AND ACADEMIC ACHIEVEMENT IN SIBLINGS WITH AND WITHOUT SICKLE CELL DISEASE : 407
DEVELOPMENT AND PRELIMINARY EVALUATION OF THE ASSESSMENT OF OPIOID TAKING BEHAVIORS AND ADHERENCE SCALE (AOTBA) IN PATIENTS WITH SICKLE CELL DISEASE : 412
CLINICAL PRESENTATION OF SICKLE CELL DISEASE FROM A SINGLE CENTER IN CENTRAL INDIA: A PROSPECTIVE ANALYSIS : 245
Depressive Symptoms and Disease Management Self Efficacy, Not Catastrophizing, Predict Pain Interference Independent of Pain Severity in Sickle Cell Disease: Results from the baseline IMPORT study. : 296
IMPROVING EMERGENCY DEPARTMENT CARE FOR CHILDREN WITH SICKLE CELL DISEASE : 307
SOCIAL BEHAVIORAL NEEDS OF PATIENTS WITH SICKLE CELL DISEASE : 309
A REVIEW OF VITAMIN D DEFICIENCY, TREATMENT AND PATIENT KNOWLEDGE AMONG SICKLE DISEASE PATIENTS AND PARENTS : 330
SICKLE CELL CONNECTS WITH THE CHRONIC PAIN SERVICE: A COLLABORATIVE CLINIC A QUALITY IMPROVEMENT PROJECT : 239
NUTRITIONAL IMPACT OF SICKLE CELL ANEMIA: OBESITY CAN ALSO BE A PROBLEM IN SICKLE CELL ANEMIA : 313
APPLICATION OF CLINICAL MICROSYSTEMS TO IMPROVE THE OUTPATIENT CARE OF PATIENTS WITH SICKLE CELL DISEASE (SCD) : 359
PERCEIVED RACISM AND STIGMA AMONG ADOLESCENTS WITH SICKLE CELL DISEASE : 398
VITAMIN D DEFICIENCY IN AN ADULT POPULATION WITH SICKLE CELL DISEASE : 403
Jonathan Douglas Santoro, MS, : 410
SPINAL INFARCTION IN SICKLE CELL DISEASE, A RARE AND UNEXPLAINED COMPLICATION : 298
READINESS CHECKLIST: PREPARING FOR TRANSFER OF MEDICAL CARE : 333
PROGRAM FOR CONTINUING LEARNING ON SICKLE CELL DISEASE FOR PRIMARY HEALTH CARE PROFESSIONALS IN THE STATE OF MINAS GERAIS, BRAZIL : 384
PATIENT CENTERED APPROACH TO DESIGNING SICKLE CELL TRANSITION EDUCATION : 415
AT THE CROSSROADS OF INFLAMMATION AND COAGULATION: HSP90 INHIBITION IN SICKLE CELL DISEASE : 251
NATIONAL ESTIMATES OF SICKLE CELL DISEASE WITH PEDIATRIC STROKE AMONG AFRICAN-AMERICANS—UNITED STATES, 1997-2009 : 385
AN ASSESSMENT OF DISEASE KNOWLEDGE DIFFERENCESBETWEEN ADOLESCENTS WITH SICKLE CELL DISEASE AND THEIR CAREGIVERS AND ITS CORRELATION TO QUALITY OF LIFE : 394
DEVELOPMENT AND PRELIMINARY VALIDATION OF A MULTI-DIMENSIONAL ELECTRONIC PAIN DIARY FOR CHILDREN WITH SICKLE CELL DISEASE : 408
ASPEN SYNDROME REVISITED (ASSOCIATION OF SICKLE CELL DISEASE, PRIAPISM, EXCHANGE TRANSFUSION AND NEUROLOGICAL EVENTS) : 405
SPONTANEOUS EPIDURAL HEMATOMA COMPLICATING SICKLE CELL ANEMIA : 240
Beta-S gene prevalence among socio-economically disadvantaged ethnic groups in Central India : 349
A NOVEL IMAGING MODALITY FOR MANAGEMENT OF SICKLE CELL DISEASE PATIENTS WITH MOYAMOYA SYNDROME : 396
MANAGEMENT AND MEASUREMENT OF PRURITUS IN SICKLE CELL DISEASE PATIENTS (SCD) : 421
UTILIZING REFLECTIVE WRITING TO IMPROVE MEDICAL EDUCATION AND CULTURAL COMPETENCE REGARDING THE CARE OF SICKLE CELL DISEASE : 430
PROCESS OF DISSEMINATING KNOWLEDGE ON SICKLE CELL DISEASE TO PRIMARY HEALTH CARE PROFESSIONALS IN THE STATE OF MINAS GERAIS, BRAZIL : 390
PILOT PROGRAM FOR ESCAPE: ELECTRONIC SICKLE CELL APPLICATION FOR PAIN EVALUATION FOR PATIENTS ENROLLED IN NKT 120-SCD1 : 250
PEER MENTORING FOR ADOLESCENTS AND YOUNG ADULTS WITH SICKLE CELL DISEASE : 255
ERYTHROPOIETIN LEVEL IN SICKLE CELL DISEASE PATIENTS NOT IN CRISIS : 301
EFFECTS OF DENTAL CARE ON ACUTE CARE UTILIZATION FOR INDIVIDUALS WITH SICKLE CELL DISEASE : 342
LONGITUDINAL ANALYSIS OF EMOTIONAL AND BEHAVIORAL PROBLEMS IN YOUTH WITH SICKLE CELL DISEASE USING THE PROBLEM SYMPTOM CHECKLIST-17 : 373
DEVELOPMENT OF A MULTI-DISCIPLINARY INPATIENT PROGRAM FOR CHILDREN WITH SICKLE CELL DISEASE ADMITTED FOR VASO-OCCULUSIVE CRISIS : 247
RAPIDLY FATAL PNEUMOCOCCAL SEPSIS IN A YOUNG ADULT WITH SICKLE CELL DISEASE : 258
EFFECT OF VITAMIN D AND CALCIUM SUPPLEMENTATION ON BONE MINERAL DENSITY IT PEDIATRIC SICKLE CELL DISEASE PATIENTS : 365
MOBILE DIRECTLY OBSERVED THERAPY: MONITORING AND IMPROVING HYDROXYUREA ADHERENCE IN PEDIATRIC SICKLE CELL PATIENTS : 424
IMPROVING HEALTH LITERACY AMONG THE SOCIO-ECONOMICALLY DISADVANTAGED SCHEDULED TRIBES FOR SICKLE CELL AND OTHER DISEASES IN SOUTHERN INDIA : 331
ETHICAL AND CLINICAL CONSIDERATIONS IN AN ADOLESCENT JEHOVAH'S WITNESS WITH SICKLE CELL ANEMIA : 425
PERCEPTIONS OF HOSPITAL READMISSION IN PATIENTS DIAGNOSED WITH SICKLE CELL DISEASE : 420
EFFECT OF WEATHER ON FREQUENCY OF VASO-OCCLUSIVE CRISIS IN CHILDREN WITH SICKLE-CELL DISEASE IN OUR POPULATION : 392
EFFECTIVENESS OF EDUCATIONAL INTERVENTION IN IMPROVING KNOWLEDGE AND PERCEPTION AMONG HEALTHCARE PROVIDERS AT A COMMUNITY-BASED HOSPITAL : 413
SAFETY AND LONG-TERM EFFECTS OF SPLENECTOMY AT THE AGE OF TWO FOR ACUTE SPLENIC SEQUESTRATION IN SICKLE CELL DISEASE: A RETROSPECTIVE REVIEW : 417
HYDROXYUREA THERAPY IN SICKLE CELL DISEASE: AN ALTERNATIVE APPROACH TO PREOPERATIVE RED CELL TRANSFUSION? : 422
EPIDEMIOLOGY AND VARIABLES DEFINING SEVERITY OF SICKLE CELL DISEASE: A SINGLE INSTITUTION EXPERIENCE : 253
ASYMMETRICAL IMPACT OF SICKLE CELL ANEMIA ON CARDIAC CAVITIES : 423
(A) THE LUNGS AND BRAIN IN SICKLE CELL DISEASE: ORGANS AT RISK OF INJURY DUE TO PERTURBATIONS IN THE HEME DEGRADATION PATHWAY : 366
(A) NEWBORN SCREENING FOR SICKLE CELL DISEASE AND OTHER HEMOGLOBINOPATHIES IN IBADAN, NIGERIA : 372
IN VITRO HUMAN AND PRECLINICAL ANIMAL STUDIES OF ADENOSINE-BASED THERAPIES IN SICKLE CELL DISEASE : 428
FINAL RESULTS OF A RANDOMIZED, OPEN-LABEL, MULTICENTER, 26-WEEK DOSE ESCALATION STUDY OF HQK-1001 (2,2-DIMETHYLBUTYRATE, SODIUM SALT) IN SICKLE CELL DISEASE (SCD) : 299
STUDIES OF CLINICAL STAGE HBF INDUCERS IN SUB-GENOTYPED SICKLE ERYTHROID PROGENITORS AND PRIMATES : 361
DISCOVERY AND HIGH-THROUGHPUT SCREENING AT THE UNIVERSITY OF KANSAS : 370
ASE 1, FIRST-IN-MAN, DOSE-RESPONSE STUDY OF AES-103 (5-HMF), AN ANTI-SICKLING, ALLOSTERIC MODIFIER OF HEMOGLOBIN OXYGEN AFFINITY IN HEALTHY NORMAL VOLUNTEERS : 358
lot Study of Eptifibatide for Treatment of Acute Pain Episodes in Sickle Cell Disease : 235
LOST IN TRANSLATION: COMPLEX INTERACTIONS IN SICKLE CELL DISEASEMAY INTERFERE WITH TARGETED THERAPEUTICS : 411
EVALUATION OF PURIFIED POLOXAMER 188 IN CHILDREN (EPIC) - KEY DESIGN CONSIDERATIONS : 364
A PHASE I SINGLE ASCENDING DOSE STUDY OF NKTT120 IN STABLE ADULT SCD PATIENTS : 351
IS THERE A ROLE FOR A RHEOLOGIC AGENT IN TRANSFUSION? : 362
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, EFFICACY AND SAFETY COMPARISON OF PRASUGREL AND PLACEBO IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE : 433